Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

KYTX - Kyverna Therapeutics Inc.

IEX Last Trade
8.08
0.060   0.743%

Share volume: 386,769
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$8.02
0.06
0.75%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
4%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 10%
Performance
5 Days
-0.74%
1 Month
-8.23%
3 Months
-34.82%
6 Months
-71.39%
1 Year
-73.23%
2 Year
-73.23%
Key data
Stock price
$8.08
P/E Ratio 
0.00
DAY RANGE
$7.85 - N/A
EPS 
$0.00
52 WEEK RANGE
$6.30 - $35.06
52 WEEK CHANGE
-$0.73
MARKET CAP 
346.469 M
YIELD 
N/A
SHARES OUTSTANDING 
43.147 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
BETA 
1.35
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$295,179
AVERAGE 30 VOLUME 
$486,396
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news